Anavex Life Sciences Corp (AVXL)

[JWC3]

I don’t know if any surprise format; however, Dr M has followed more than 100 patients that have finished their dosing regimens in PDD over 16 weeks ago for at least 16 weeks under the Open Lable Extension trial that follows in sequence the PDD trial. He can at that time comment on his findings in OLE data that he has observed and reveal how they performed after the trial based on the dosing information that was blinded totally, and after the trial dosing has been unblinded. That information could possibly revealed as early as April 20,2020!